Monday, October 12, 2015

Scientific Health Development Backs MiNDERA

Dallas-based life sciences investor Scientific Health Development has backed the developer of a molecular diagnostics test for skin cancer this morning. MiNDERA, which is developing micro-needle technology for sampling skin for dermatology and skin-related cancers, said it had raised $1M in a seed funding round this morning, led by Scientific Health Development, and also including individuals. Andrew Offer of Scientific Health Development joins the company's board as part of the funding. Scientific Health Development closed its third fund, SHD III, earlier this year. More information »